Drug
Rotigotine Transdermal
Rotigotine Transdermal: highest development phase Phase 1, developed by UCB. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- UCB
Trials
| Drug | Phase | Indication |
|---|---|---|
| Rotigotine transdermal patch NCT01338896 | Phase 1 | Parkinson's Disease |
Latest
No recent events.
Follow Rotigotine Transdermal on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.